Valneva SE (VALN) Intangibles (2020 - 2026)
Valneva SE's (VALN) quarterly Intangibles came in at $25.3 million in Q1 2026, down 2.12% year-on-year from $25.9 million in Q1 2025, and down 2.66% quarter-over-quarter from $26.0 million in Q4 2025.
Valneva SE (VALN) Intangibles (2020 - 2026) Analysis & Trends
Valneva SE has disclosed Intangibles across 7 years of filings, most recently posting $25.3 million for Q1 2026.
- Intangibles for Q1 2026 came in at $25.3 million, down 2.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.3 million (down 2.12% YoY), and the FY2025 annual result was $26.0 million, down 3.61% from the prior year.
- Intangibles came in at $25.3 million for Q1 2026 at Valneva SE, down from $26.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $36.8 million in Q3 2024 to a low of $25.3 million in Q1 2026.
- The 5-year median for Intangibles is $27.5 million (2023), against an average of $28.9 million.
- Across the five-year window, Intangibles increased 28.22% in 2024 and fell 26.63% in 2025, its largest moves.
- Valneva SE's Intangibles stood at $29.3 million in 2022, then slipped by 6.09% to $27.5 million in 2023, then declined by 1.88% to $27.0 million in 2024, then slipped by 3.61% to $26.0 million in 2025, then decreased by 2.66% to $25.3 million in 2026.
- The last three Intangibles figures came in at $25.3 million (Q1 2026), $26.0 million (Q4 2025), and $27.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 7.73 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 25.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.32 Mn |
| Dec 31, 2025 | 26.02 Mn |
| Sep 30, 2025 | 26.97 Mn |
| Jun 30, 2025 | 26.97 Mn |
| Mar 31, 2025 | 25.87 Mn |
| Dec 31, 2024 | 26.99 Mn |
| Sep 30, 2024 | 36.77 Mn |
| Jun 30, 2024 | 26.05 Mn |
| Mar 31, 2024 | 27.00 Mn |
| Dec 31, 2023 | 27.51 Mn |
| Sep 30, 2023 | 28.67 Mn |
| Jun 30, 2023 | 29.54 Mn |
| Mar 31, 2023 | 29.94 Mn |
| Dec 31, 2022 | 29.29 Mn |
| Sep 30, 2022 | 29.90 Mn |
| Jun 30, 2022 | 32.77 Mn |
| Mar 31, 2022 | 35.65 Mn |
| Dec 31, 2021 | 37.41 Mn |
| Dec 31, 2020 | 42.22 Mn |